NDC 46066-219 - CMPK
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 46066-219
- Package NDCs from labels
- 46066-219-25
- Manufacturer
- Aspen Veterinary Resources, Ltd.
- Effective date
- 2018-04-26
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| CMPK Solution | Aspen Veterinary Resources, Ltd. | 2018-04-26 | OTC ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 46066-219-25 | CMPK | 500 mL in 1 BOTTLE | SOLUTION | 500 | 1 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Kali Mur | KALI MURIATICUM | Energique, Inc. | db9894e6-2de0-428e-b553-11bb39a1d711 | 2023-01-04 | Warnings | 660YQ98I10 |
| Dextrose Monohydrate | DEXTROSE MONOHYDRATE | International Medication Systems, Limited | fcc7ac79-cd70-4f03-a4de-f051f9ca1f7d | 2022-12-20 | Warnings, Adverse reactions | LX22YL083G |
| KALI MURIATICUM | POTASSIUM CHLORIDE | Hyland's Inc. | 2e8a4762-d28d-4b64-892f-913e04d18d2d | 2022-12-19 | Warnings | 660YQ98I10 |
| Dr Talbots Infant Pain Fever Relief | CALENDULA OFFICINALIS 12X,CHAMOMILLA 12X,ECHINACEA ANGUSTIFOLIA 12X,EUPATORIUM PERFOLIATUM 12X,HEPAR SULPHURIS CALCAREUM 12X,SULPHUR 12X,FERRUM PHOSPHORICUM 12X,KALI MURIATICUM 6X | Talbot's Pharmaceuticals Family Products,LLC. | e881a3ce-8cf9-0ce6-e053-2995a90ae824 | 2022-12-16 | Warnings | 660YQ98I10 |
| EARACHE DROPS | BELLADONNA LEAF, CALCIUM CARBONATE, CHAMOMILE, LYCOPODIUM CLAVATUM SPORE, ANEMONE PATENS, AND SULFUR | Hyland's Inc. | 9b18453e-e338-4b8e-9856-85aca8c46ee1 | 2022-12-12 | Warnings | H0G9379FGK |
| 25% Dextrose Infant | 25% DEXTROSE INFANT | HF Acquisition Co. LLC, DBA Health First | 73d04839-a2bb-65dd-e053-2991aa0a82ca | 2022-12-09 | Warnings, Adverse reactions | LX22YL083G |
| Dextrose | DEXTROSE MONOHYDRATE | Baxter Healthcare Company | 9c80dfee-8923-4d1f-85b0-98bd68b94212 | 2022-12-07 | Warnings, Adverse reactions | LX22YL083G |
| Dextrose | DEXTROSE MONOHYDRATE | Baxter Healthcare Corporation | 50603082-bce5-49eb-9737-e04239cfb695 | 2022-12-07 | Warnings, Adverse reactions | LX22YL083G |
| OSTEOBIOS | CALCITONIN HUMAN - CALCIUM CARBONATE - CALCIUM FLUORIDE - CALCIUM PHOSPHATE - ISOLEUCINE - LEUCINE - LYSINE - METHIONINE - PHENYLALANINE - SUS SCROFA BONE - SUS SCROFA PARATHYROID GLAND - THREONINE - TRYPTOPHAN - VALINE - | Guna spa | 1b8c8c83-1a46-4c0a-b883-e7dce781c5d1 | 2022-11-14 | Warnings | H0G9379FGK |
| Multiple Electrolytes pH 7.4 | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE AND MAGNESIUM CHLORIDE | Fresenius Kabi USA, LLC | 84221110-b3f1-42f4-800c-ad1d3b330e9e | 2022-11-10 | Warnings, Adverse reactions | 02F3473H9O 660YQ98I10 |
| Multiple Electrolytes pH 5.5 | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE AND MAGNESIUM CHLORIDE | Fresenius Kabi USA, LLC | cf1f5f15-d31d-4a02-8f7e-b289d5ad4b5c | 2022-11-10 | Warnings, Adverse reactions | 02F3473H9O 660YQ98I10 |
| Anticoagulant Citrate Phosphate Dextrose (CPD) Blood-Pack Units in PL 146 Plastic | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION | Fenwal, Inc. | d55cb701-9664-4931-8754-1a8cae68da06 | 2022-11-01 | LX22YL083G | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE (CPDA-1) SOLUTION | Fenwal, Inc. | f9d7f1b4-7a77-44f9-8924-10b16008b49d | 2022-11-01 | LX22YL083G | |
| Anticoagulant Citrate Phosphate Dextrose (CPD) Blood-Pack Units in PL 146 Plastic | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) | Fenwal, Inc. | 4a08a9ec-46a5-4fcf-80ee-5c33f1a8b746 | 2022-11-01 | LX22YL083G | |
| Potassium Chloride | POTASSIUM CHLORIDE | Zydus Pharmaceuticals (USA) Inc. | 31e02249-7984-4b8f-9e37-2b79b708ac08 | 2022-10-18 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Zydus Lifesciences Limited | 099c3a36-f460-4191-80e5-0c4153a5c713 | 2022-10-18 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | BluePoint Laboratories | 73c911bb-4d39-4793-acba-90ed4b0eff46 | 2022-10-17 | Warnings, Adverse reactions | 660YQ98I10 |
| Dextrose | DEXTROSE MONOHYDRATE | Medical Purchasing Solutions, LLC | 66713d9c-f404-4ec8-e053-2a91aa0a620a | 2022-10-13 | Warnings, Adverse reactions | LX22YL083G |
| Dextrose | DEXTROSE MONOHYDRATE | Medical Purchasing Solutions, LLC | 677bb6d6-704b-5be5-e053-2991aa0a5f6f | 2022-10-13 | Warnings, Adverse reactions | LX22YL083G |
| Dextrose Monohydrate | DEXTROSE MONOHYDRATE | Medical Purchasing Solutions, LLC | dc6664a6-1be1-676c-e053-2995a90a3490 | 2022-10-07 | Warnings, Adverse reactions | LX22YL083G |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.